Stocks and Investing
Stocks and Investing
Thu, January 3, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, January 2, 2019
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
David Lewis Maintained (ZBH) at Buy with Decreased Target to $126 on, Jan 2nd, 2019
David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Decreased Target from $149 to $126 on, Jan 2nd, 2019.
David has made no other calls on ZBH in the last 4 months.
There are 3 other peers that have a rating on ZBH. Out of the 3 peers that are also analyzing ZBH, 0 agree with David's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with David
- Matthew Taylor of "UBS" Initiated at Strong Buy and Held Target at $140 on, Wednesday, November 28th, 2018
- Travis Steed of "Barclays" Maintained at Sell with Decreased Target to $119 on, Monday, October 29th, 2018
- Anthony Petrone of "Jefferies" Maintained at Strong Buy with Decreased Target to $140 on, Monday, October 29th, 2018
Contributing Sources